A 3-year Multi-center Study to Describe Changes of OCT Parameters Under Treatment With Gilenya® — PASSOS  

Relapsing Remitting Multiple Sclerosis RRMS Clinical Trial

Official title: A 3-year Multi-center Study to Describe the Long Term Changes of Optical Coherence Tomography (OCT) Parameters in Patients Under Treatment With Gilenya®

Status Completed

Clinical Trial Summary

This was a 3-year, prospective, multi-center, open-label study to describe the long term changes of optical coherence tomography (OCT) parameters in RRMS patients under treatment with Fingolimod. It was designed to longitudinally study the degeneration of retinal axons by measuring change in RNFL thickness by latest OCT-technology.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Multiple Sclerosis
• Multiple Sclerosis, Relapsing-Remitting
• Relapsing Remitting Multiple Sclerosis RRMS
• Sclerosis

• NCT number: NCT01705236
• Study type: Interventional
• Source: Novartis
• Status: Completed
• Phase: Phase 4
• Start date: August 20, 2012
• Completion date: February 18, 2019